Skip to main content
. 2017 Mar 13;11:519–530. doi: 10.2147/PPA.S129333

Table 2.

Patient acceptance of biosimilars

Patient status Biologic naive Biooriginator patients in need of switch for clinical reasons Biooriginator patients not in need of switch for clinical reasons
Patients accepted without reluctance (%)
 N 48 48 48
 Mean 71.2 61.3 56.3
 SD 28.46 28.94 34.88
Patients reluctant but accepted as no other choice (%)
 N 48 48 48
 Mean 16.1 23.5 19.6
 SD 17.88 20.31 19.14
Patients refused but accepted biooriginator (%)
 N 48 48 48
 Mean 7.3 10.8 18.5
 SD 10.74 13.14 24.43
Patients refused biosimilar and biooriginator (%)
 N 48 48 48
 Mean 5.4 4.4 5.6
 SD 7.42 6.33 8.29

Note: N, number of rheumatologists responding.

Abbreviation: SD, standard deviation.